BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12194910)

  • 1. New markers for kidney disease.
    Star R; Hostetter T; Hortin GL
    Clin Chem; 2002 Sep; 48(9):1375-6. PubMed ID: 12194910
    [No Abstract]   [Full Text] [Related]  

  • 2. New Markers of Renal Diseases. Proceedings of a meeting. Telfs, Tyrol, Austria, October 6-8, 1993.
    Kidney Int Suppl; 1994 Nov; 47():S1-141. PubMed ID: 7869655
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent successes in the identification, development, and qualification of translational biomarkers: the next generation of kidney injury biomarkers.
    Ennulat D; Adler S
    Toxicol Pathol; 2015 Jan; 43(1):62-9. PubMed ID: 25492424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opponent's comments.
    Kretzler M; Mariani LH
    Nephrol Dial Transplant; 2015 Jun; 30(6):891. PubMed ID: 25994658
    [No Abstract]   [Full Text] [Related]  

  • 5. Searching for new biomarkers of renal diseases through proteomics.
    Konvalinka A; Scholey JW; Diamandis EP
    Clin Chem; 2012 Feb; 58(2):353-65. PubMed ID: 21980170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderator's view: Biomarkers in glomerular diseases--translated into patient care or lost in translation?
    Ronco P
    Nephrol Dial Transplant; 2015 Jun; 30(6):899-902. PubMed ID: 25994661
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein and Peptide Studies in Kidney Disease: Prediction, Diagnosis and Treatment.
    Huang J
    Protein Pept Lett; 2018; 25(6):512-513. PubMed ID: 30187837
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteomic biomarkers in kidney disease: issues in development and implementation.
    Mischak H; Delles C; Vlahou A; Vanholder R
    Nat Rev Nephrol; 2015 Apr; 11(4):221-32. PubMed ID: 25643662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Frontiers: Approaches to Understand the Mechanistic Basis of Renal Toxicity.
    Nabity MB; Polli JW; Vaidya V; Krolewski A; Glaab WE
    Toxicol Pathol; 2018 Dec; 46(8):1002-1005. PubMed ID: 30189777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-acetyl-beta-D-glucosaminidase and its clinical significance].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Arch Med Wewn; 1999 Apr; 101(4):359-66. PubMed ID: 10740416
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystatin C: a promising misunderstood biomarker for the diagnosis of acute kidney injury.
    Ferrannini M; Vischini G; Di Daniele N
    Kidney Int; 2008 Dec; 74(12):1623; author reply 1623-4. PubMed ID: 19034305
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspective on Clinical Application of Biomarkers in AKI.
    Parikh CR; Mansour SG
    J Am Soc Nephrol; 2017 Jun; 28(6):1677-1685. PubMed ID: 28220028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenofibrotic Glomerulopathy.
    Chen T; Achan A; Li K; Harris D
    Nephrology (Carlton); 2018 Jun; 23(6):601-602. PubMed ID: 29890045
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein biomarkers associated with acute renal failure and chronic kidney disease.
    Perco P; Pleban C; Kainz A; Lukas A; Mayer G; Mayer B; Oberbauer R
    Eur J Clin Invest; 2006 Nov; 36(11):753-63. PubMed ID: 17032342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen type III glomerulopathy.
    Pizzo HP; Haas M; Puliyanda D
    Kidney Int; 2018 Jun; 93(6):1490. PubMed ID: 29792275
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary biomarkers of kidney dysfunction].
    Piéroni L; Cristol JP
    Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in chronic kidney disease: a review.
    Fassett RG; Venuthurupalli SK; Gobe GC; Coombes JS; Cooper MA; Hoy WE
    Kidney Int; 2011 Oct; 80(8):806-21. PubMed ID: 21697815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of urinary proteomics for the detection of biomarkers of kidney diseases.
    Jiang S; Wang Y; Liu Z
    Adv Exp Med Biol; 2015; 845():151-65. PubMed ID: 25355578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.
    Chen L; Su W; Chen H; Chen DQ; Wang M; Guo Y; Zhao YY
    Adv Clin Chem; 2018; 85():91-113. PubMed ID: 29655463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.